Liraglutide vs. Semaglutide
Compare Liraglutide and Semaglutide: mechanism of action, indications, side effects, cost, and which may be right for you.
Quick Comparison
| Category | Liraglutide | Semaglutide |
|---|---|---|
| Drug Class | GLP-1 Receptor Agonists | GLP-1 Receptor Agonists |
| Rx Status | Rx | Rx |
| Generic Available | No | No |
| Typical Cost | $900–$1,200/month | $935–$1,349/month |
Liraglutide Overview
Liraglutide (Victoza) is a type of medicine that mimics a natural hormone in your body. It is prescribed to help adults and children aged 10 and older with type 2 diabetes manage their blood sugar levels, and it can also lower the risk of serious heart problems like heart attack or stroke in adults with type 2 diabetes and existing heart disease. It works by helping your body release insulin when ...
Full Liraglutide guide →Semaglutide Overview
Semaglutide is a once-weekly (or once-daily oral) GLP-1 receptor agonist that lowers blood sugar and reduces body weight by mimicking the natural gut hormone GLP-1. It is sold under three brand names — Ozempic (injectable, type 2 diabetes), Wegovy (injectable, weight management), and Rybelsus (oral tablet, type 2 diabetes) — all manufactured by Novo Nordisk. Clinical trials show it reduces HbA1c b...
Full Semaglutide guide →How Each Drug Works
Liraglutide
Liraglutide is an acylated human GLP-1 receptor agonist with 97% amino acid sequence homology to endogenous human GLP-1(7-37). GLP-1(7-37) represents <20% of total circulating endogenous GLP-1. Like GLP-1(7-37), liraglutide activates the GLP-1 receptor, a membrane-bound cell-surface receptor coupled to adenylyl cyclase by the stimulatory G-protein, Gs, in pancreatic beta cells. Liraglutide increases intracellular cyclic AMP (cAMP) leading to insulin release in the presen…
Semaglutide
Semaglutide is a GLP-1 receptor agonist — it selectively binds to and activates the GLP-1 receptor, mimicking the effects of the endogenous hormone GLP-1 that is released from intestinal L-cells after eating.
GLP-1 receptor activation produces:
- Glucose-dependent insulin secretion — stimulates first- and second-phase insulin release from pancreatic beta cells only when blood glucose is elevated, reducing the risk of hypoglycemia
- Glucagon suppression — inhibits glucagon secret…
Approved Uses (Indications)
Liraglutide
1 INDICATIONS AND USAGE VICTOZA is indicated:
- as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus,
- to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease. Limitations of Use: VICTOZA contains liraglutide. Coadministration with other liraglutide-containing products is not recommended. VICTOZA is a glucagon-like peptide-1 (GLP-1) receptor …
Semaglutide
Ozempic (semaglutide injectable, 0.5–2 mg) is FDA-approved for:
- Type 2 diabetes mellitus — as an adjunct to diet and exercise to improve glycemic control in adults
- Cardiovascular risk reduction — to reduce the risk of major adverse cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
Wegovy (semaglutide injectable, 2.4 mg) is FDA-approved for:
- Chronic weight management in adults with initial BMI ≥30 kg/m² (obesity), or ≥27 kg/m² (overweight) with at …
Side Effects
Liraglutide
Semaglutide
Serious Side Effects
Common Side Effects
Rare Side Effects
Cost Comparison
Liraglutide
$900–$1,200/month
As Liraglutide is brand-only, manufacturer savings programs or patient assistance programs are often the best way to significantly reduce out-of-pocket costs.
Semaglutide
$935–$1,349/month
Semaglutide is available under three brand names with different pricing structures: **Ozempic (injectable, diabetes indication):** - List price: approximately $935–$968 per 4-week supply (all doses) - With Novo Nordisk savings card: as low as $25/month for eligible commercially insured patients - Medicare Part D: covered for type 2 diabetes; prior authorization typically required **Wegovy (injectable, weight management):** - List price: approximately $1,349/month - With Novo Nordisk savings card: as low as $25/month for eligible commercially insured patients - Medicare Part D: covered for weight management (Inflation Reduction Act, 2024) and for cardiovascular risk reduction (SELECT indication); ~$50–$100/month copay typical **Rybelsus (oral tablet):** - List price: approximately $935–$968/month (same as Ozempic) - With Novo Nordisk savings card: as low as $10/month for eligible commercially insured patients - Medicare Part D: covered for type 2 diabetes No FDA-approved generic semaglutide exists as of 2026. Compounded semaglutide is no longer permitted under the shortage exemption following the FDA's declaration that the shortage has been resolved (March 2025 for Ozempic/Wegovy; April 2025 for Rybelsus).
Drug Interaction: Moderate
Combining semaglutide and liraglutide, both GLP-1 receptor agonists, is generally not recommended. This combination is unlikely to provide additional glycemic control or weight loss benefits beyond monotherapy, but significantly increases the risk of dose-dependent adverse effects.
Mechanism: Both semaglutide and liraglutide act as glucagon-like peptide-1 (GLP-1) receptor agonists, stimulating insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. Concomitant use leads to additive pharmacological effects on the GLP-1 receptor.
Compare prices for Liraglutide and Semaglutide
Check real-time pharmacy prices before you fill — free, no account needed.
Protect your muscle mass on GLP-1 medications
GLP-1 medications can cause up to 39% muscle loss alongside fat. Zova's AI-powered protocol — backed by Lancet Diabetes & Endocrinology research — reduces that to just 8.7% through leucine tracking and injection-day adaptive nutrition.
No credit card. No commitment.
Medical Disclaimer
The information on RxGuide is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.